Yüklüyor......
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
The addition of trastuzumab to the treatment of a subset of patients with advanced gastric and gastroesophageal junction cancers showing HER2 positivity has been shown to confer clinical benefit; however, questions remain over the optimal methods for defining and selecting such patients. This review...
Kaydedildi:
| Yayımlandı: | Onco Targets Ther |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135398/ https://ncbi.nlm.nih.gov/pubmed/27932891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100643 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|